Nonalcoholic fatty liver disease: new treatments

Current Opinion in Gastroenterology
Timothy HardyChristopher Paul Day

Abstract

Nonalcoholic fatty liver disease is the most common cause of liver dysfunction in the western world because of its close association with obesity, insulin resistance and dyslipidaemia. Nonalcoholic steatohepatitis (NASH) is a particular health concern due to the increased morbidity and mortality associated with progressive disease. At present, without specific targeted pharmacological therapies, the mainstay of therapy remains weight loss through dietary modification and lifestyle change; thus, the purpose of this review is to summarize the recent evidence for current and emerging therapies in NASH. Some existing medications, including pioglitazones and angiotensin receptor antagonists, may be repurposed to help treat this condition. Vitamin E may improve histology in NASH, but safety issues limit its use. Recently, a number of novel agents specifically targeting nonalcoholic fatty liver disease pathogenesis have entered clinical trials, including the farnesoid X receptor agonist obeticholic acid, which has shown significant histological improvements in steatohepatitis and fibrosis. Diet/lifestyle modification remains the mainstay of treatment. For patients with NASH and advanced fibrosis, current liver-directed pharmacotherapy...Continue Reading

References

May 15, 1994·Genes & Development·P TontonozB M Spiegelman
Aug 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A M PréauxP Mavier
Sep 2, 2000·The Journal of Biological Chemistry·T MiyaharaH Tsukamoto
Sep 10, 2002·The Lancet Oncology·France BianchiniHarri Vainio
Apr 25, 2003·The New England Journal of Medicine·Eugenia E CalleMichael J Thun
Mar 5, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Keith D LindorPatrick Colin
May 8, 2004·Gastroenterology·Naga ChalasaniStephen D Hall
Sep 24, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Shiro YokohamaKimihide Nakamura
Oct 7, 2004·Journal of Hepatology·Sean W P KoppeRichard M Green
Nov 13, 2004·Annals of Internal Medicine·Edgar R MillerEliseo Guallar
Dec 31, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Arun J SanyalAlan S Mills
Dec 13, 2005·Nature Reviews. Cancer·Marie-France DemierreScott M Lippman
Feb 4, 2006·The American Journal of Gastroenterology·Kevin B BarkerStephen A Harrison
Mar 11, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Hashem B El-SeragFariba Javadi
Apr 25, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Shira Zelber-SagiRan Oren
Sep 29, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mattias EkstedtStergios Kechagias
Dec 1, 2006·The New England Journal of Medicine·Renata BelfortKenneth Cusi
Dec 15, 2006·Nature·Gökhan S Hotamisligil
Jun 15, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Glen LutchmanJay H Hoofnagle
Jul 5, 2007·Obesity Surgery·Xiuli LiuGary A Abrams
Jul 31, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jason S SodenRonald J Sokol
Sep 13, 2007·JAMA : the Journal of the American Medical Association·Sonal SinghCurt D Furberg
Oct 2, 2007·Journal of the American Dietetic Association·Marion J FranzNicolas P Pronk
Oct 18, 2007·The Annals of Pharmacotherapy·Catherine E Murphy, Philip T Rodgers
Oct 30, 2007·The Medical Clinics of North America·Manal F Abdelmalek, Anna Mae Diehl
Oct 24, 2008·Alimentary Pharmacology & Therapeutics·R LoombaJ H Hoofnagle
Oct 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yan-Dong WangWendong Huang
Oct 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Martin WagnerMichael Trauner
Dec 5, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stephen A HarrisonBrent A Neuschwander-Tetri
May 19, 2009·Journal of Clinical Gastroenterology·Austin NelsonStephen A Harrison

❮ Previous
Next ❯

Citations

Oct 18, 2015·Naunyn-Schmiedeberg's Archives of Pharmacology·Sahar El SwefyMona F Mahmoud
Mar 31, 2016·International Journal of Molecular Sciences·David HoughtonMichael Trenell
Sep 13, 2016·Scandinavian Journal of Gastroenterology·Hannes HagströmRolf Hultcrantz
Oct 30, 2016·Metabolic Syndrome and Related Disorders·Nirvair S Kelley
Apr 22, 2017·Nature Reviews. Gastroenterology & Hepatology·Nina L GluchowskiRobert V Farese
May 16, 2017·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·David HoughtonMichael I Trenell
Aug 2, 2017·Canadian Journal of Physiology and Pharmacology·Magdalena IzdebskaJarosław Dudka
Aug 5, 2017·Alimentary Pharmacology & Therapeutics·J Gallacher, S McPherson
Aug 6, 2019·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Francesco De ChiaraRajiv Jalan
Dec 11, 2019·JCI Insight·Pierre-Christian VioletMark Levine
Oct 23, 2019·Journal of Translational Internal Medicine·Shahinul AlamNazmul Hasan
Sep 15, 2018·Experimental and Therapeutic Medicine·Hessah Mohammed Al-Muzafar, Kamal Adel Amin
Apr 5, 2018·Nutrients·Mahmud MahamidAbdulla Watad
Jun 30, 2018·Oxidative Medicine and Cellular Longevity·Oren Tirosh
Aug 1, 2020·BioMed Research International·Ke PeiYunlun Li
Sep 26, 2015·Journal of Digestive Diseases·Münevver DemirHans-Michael Steffen
Jun 1, 2019·Pharmacology Research & Perspectives·Manca PovsicJuliana Bottomley
Aug 13, 2020·JGH Open : an Open Access Journal of Gastroenterology and Hepatology·Shahinul AlamNooruddin Ahmad
Jul 16, 2020·Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates·Rosellina Margherita MancinaRocco Spagnuolo
Jul 23, 2020·Nature Metabolism·Michele VaccaAntonio Vidal-Puig
Jan 28, 2017·World Journal of Gastroenterology : WJG·Tomasz KostrzewskiDavid J Hughes
Sep 2, 2017·Journal of the Science of Food and Agriculture·Arunaksharan NarayanankuttyAchuthan C Raghavamenon
Apr 11, 2019·Journal of Digestive Diseases·Asieh MansourParvin Mirmiran
Dec 19, 2020·Therapeutic Advances in Gastroenterology·Mohamed Abdel-MaboudMuhammad Eid
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jitendra ShresthaEun-Young Park
Aug 26, 2017·Microbiology Spectrum·Anne-Marie CassardGabriel Perlemuter

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
pharmacotherapies
gastric bypass
biopsy

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.